Stryker (NYSE:SYK) Insider Debra King Sells 826 Shares of Stock

Stryker Corporation (NYSE:SYK) insider Debra King sold 826 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $336.30, for a total value of $277,783.80. Following the transaction, the insider directly owned 6,210 shares in the company, valued at approximately $2,088,423. This represents a 11.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.

Stryker Stock Up 0.1%

Shares of SYK opened at $331.96 on Wednesday. The firm has a market capitalization of $127.33 billion, a price-to-earnings ratio of 34.40, a PEG ratio of 2.16 and a beta of 0.76. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $396.86. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The business’s fifty day moving average price is $325.56 and its two-hundred day moving average price is $333.05.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. The business had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The firm’s revenue for the quarter was up 9.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts predict that Stryker Corporation will post 15.02 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio is presently 36.48%.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on SYK. Argus set a $370.00 price target on shares of Stryker in a research note on Thursday, July 9th. Piper Sandler reduced their price objective on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating on the stock in a research note on Friday, July 31st. Wolfe Research lowered shares of Stryker from an “outperform” rating to a “peer perform” rating in a report on Thursday, August 13th. Citigroup reissued a “buy” rating on shares of Stryker in a research note on Thursday, August 13th. Finally, BMO Capital Markets assumed coverage on Stryker in a research report on Wednesday, July 8th. They issued an “outperform” rating and a $369.00 price target on the stock. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $386.28.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of SYK. Gables Capital Management Inc. acquired a new stake in Stryker in the second quarter worth $25,000. Kilter Group LLC bought a new position in shares of Stryker during the second quarter worth $25,000. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the 4th quarter valued at $26,000. Sankala Group LLC bought a new stake in shares of Stryker in the 4th quarter valued at $26,000. Finally, Compass Financial Management LLC bought a new stake in shares of Stryker in the 2nd quarter valued at $27,000. Institutional investors own 77.09% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.